RFPs
Vanderbilt University
Clinical and Commercial Stage Assets for Rare Indications

Clinical and Commercial Stage Assets for Rare Indications

Vanderbilt University

Vanderbilt University is seeking rare indication assets for portfolio expansion

Reference No.
RFP-2025-3128
Category
Healthcare/Medical
Due Date
December 9th, 2025

Description

A mid-cap publicly traded US pharmaceutical company specializing in rare diseases is seeking to expand their portfolio with clinical-stage and commercial assets.

Key Requirements

RFP Submission Requirements for Vanderbilt Rare Assets

Contact Information

What you’ll get when you unlock

All the details after a short form. No spam

  • Latest RFP PDF
  • Buyer contact sheet
  • Submission checklist
  • Any addenda links

Fill in your details we'll send you your RFP

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.